Blindness News and Research

RSS

New modified adult device effective, inexpensive for children with pneumonia

Pneumonia is the leading cause of infant deaths worldwide, but pediatric researchers at the University of Alabama at Birmingham have developed an effective, inexpensive way to help breathe life into children in developing countries.

6 Jul 2011

Novel drug delivery device can treat diabetes-related retinal damage

A team of engineers and scientists at the University of British Columbia has developed a device that can be implanted behind the eye for controlled and on-demand release of drugs to treat retinal damage caused by diabetes.

1 Jul 2011

Small molecule treatment holds promise for Usher syndrome

New treatment approach shall soon be ready for use in Usher syndrome patients / Publication in "Human Gene Therapy".

1 Jul 2011

Rinderpest - fatal animal disease eradicated

Rinderpest, German for cattle plague, has finally met its match and does not exist anymore. It is the first animal disease to be eradicated and only the second disease ever, after smallpox in 1980. The United Nations Food and Agriculture Organization declared Tuesday that the world was rid of Rinderpest.

30 Jun 2011

Anabasis, Scil Proteins enter license deal for rhNGF to treat eye diseases

Scil Proteins, a private biopharmaceutical company specialized in the research, development and production of recombinant proteins, today announced that it has signed an agreement with Anabasis Pharma.

30 Jun 2011

Positive results from RISE and RIDE Phase III trials of Genentech's Lucentis for diabetic macular edema

Genentech, a member of the Roche Group, today announced 24-month results from the two pivotal Phase III trials (RISE and RIDE) assessing the efficacy and safety of Lucentis (ranibizumab injection) in people with diabetic macular edema (DME).

29 Jun 2011

In vivo genome editing restores hemostasis in mouse model of blood clotting disorder

Using an innovative gene therapy technique called genome editing that hones in on the precise location of mutated DNA, scientists have treated the blood clotting disorder hemophilia in mice.

27 Jun 2011

UVA to study how the 'Call to Health' model helps African-American women manage diabetes

The University of Virginia Health System has received a $300,000 grant to study the "Call to Health" model, which uses text messages, stress reduction and other techniques to help African-American women manage type 2 diabetes.

27 Jun 2011

Bristol-Myers Squibb Foundation awards grants to empower African American women with type 2 diabetes

The Bristol-Myers Squibb Foundation today awarded five grants totaling $1.5 million to organizations that will empower African American women with type 2 diabetes to better manage their disease while also leveraging their standing as leaders in their families and communities to influence the health of those around them.

24 Jun 2011

Scientists uncover novel mechanism linked to Spinocerebellar ataxia 7

A team of scientists, led by researchers at the University of California, San Diego School of Medicine, have uncovered a novel mechanism regulating gene expression and transcription linked to Spinocerebellar ataxia 7, an inherited neurological disorder.

22 Jun 2011

Researchers identify potential cause of hereditary, progressive blindness

Medics at the RUB have found the cause of hereditary, progressive blindness: they have identified the previously unknown protein CCDC66, the loss of which initially leads to night blindness and in due course usually results in complete blindness.

22 Jun 2011

Oxford BioMedica reports RetinoStat progress in Phase I study against wet AMD

Oxford BioMedica plc, a leading gene therapy company, today announces that the first dose level of RetinoStat is safe and well-tolerated at one month following treatment.

22 Jun 2011

Wayne State team receives $330,000 NSF grant to develop 3-D neural probe for tinnitus

A team of Wayne State University researchers was awarded $330,000 from the National Science Foundation (NSF) to develop a 3-D neural probe. Their aim is to develop an implantable device that will suppress tinnitus, a neurological disorder that affects more than 250 million people worldwide.

21 Jun 2011

Lilly, Boehringer Ingelheim to present new data from diabetes portfolio at ADA scientific sessions

Boehringer Ingelheim and Lilly will present the latest data from their diabetes portfolio at the 71st American Diabetes Association (ADA) Scientific Sessions in San Diego on June 25-29.

21 Jun 2011

JDRF launches clinical trials network for treatment of type 1 diabetes

Juvenile Diabetes Research Foundation (JDRF) Canada has announced the official launch of its large-scale effort to support clinical trials evaluating new treatments and technologies for type 1 diabetes in Canada.

21 Jun 2011

MA launches national campaign to raise awareness on meningitis

This Father's Day is a special day for Angels Dads on Meningitis (ADOM). Angel dads from across the country came together in Denver, Colorado to launch a national campaign on meningitis awareness.

20 Jun 2011

Cedars-Sinai receives National Eye Institute grant to develop gene therapy for corneal disease

Cedars-Sinai stem cell researchers investigating ways to prevent eye problems in diabetic patients have been awarded a $3 million grant from the National Eye Institute to develop gene therapy in corneal stem cells to alleviate damage to corneas that can cause vision loss.

17 Jun 2011

Stem cell technology corrects genetic defect in rare blinding disorder

Researchers have used cutting-edge stem cell technology to correct a genetic defect present in a rare blinding disorder, another step on a promising path that may one day lead to therapies to reverse blindness caused by common retinal diseases such as macular degeneration and retinitis pigmentosa which affect millions of individuals.

16 Jun 2011

Botox injections can reduce wrinkles with half as many sessions after 20 months

Patients receiving Botox Cosmetic treatments can reduce wrinkles with half as many sessions after 20 months, according to research conducted at Oregon Health & Science University's Casey Eye Institute.

15 Jun 2011

Poor maternal nutrition predisposes offspring to type 2 diabetes

A new study published by the American Physiological Society offers the strongest evidence yet that vulnerability to type 2 diabetes can begin in the womb, giving new insight into the mechanisms that underlie a potentially devastating disease at the center of a worldwide epidemic.

14 Jun 2011

Blindness News and Research

New modified adult device effective, inexpensive for children with pneumonia

Novel drug delivery device can treat diabetes-related retinal damage

Small molecule treatment holds promise for Usher syndrome

Rinderpest - fatal animal disease eradicated

Anabasis, Scil Proteins enter license deal for rhNGF to treat eye diseases

Positive results from RISE and RIDE Phase III trials of Genentech's Lucentis for diabetic macular edema

In vivo genome editing restores hemostasis in mouse model of blood clotting disorder

UVA to study how the 'Call to Health' model helps African-American women manage diabetes

Bristol-Myers Squibb Foundation awards grants to empower African American women with type 2 diabetes

Scientists uncover novel mechanism linked to Spinocerebellar ataxia 7

Researchers identify potential cause of hereditary, progressive blindness

Oxford BioMedica reports RetinoStat progress in Phase I study against wet AMD

Wayne State team receives $330,000 NSF grant to develop 3-D neural probe for tinnitus

Lilly, Boehringer Ingelheim to present new data from diabetes portfolio at ADA scientific sessions

JDRF launches clinical trials network for treatment of type 1 diabetes

MA launches national campaign to raise awareness on meningitis

Cedars-Sinai receives National Eye Institute grant to develop gene therapy for corneal disease

Stem cell technology corrects genetic defect in rare blinding disorder

Botox injections can reduce wrinkles with half as many sessions after 20 months

Poor maternal nutrition predisposes offspring to type 2 diabetes

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News